Conferences
Speak to our team at these upcoming events.
Spreading the word about our life-changing work is a top priority for the HealthWell Foundation. Throughout the year, we travel across the country to educate patients, pharmacies, providers, caregivers, patient advocates and navigators about our programs and services so we can assist even more patients in need.
Attending one or more of the events below? Stop by to see us!!
Where We’re Going
American Society of Clinical Oncology (ASCO) May 31-June 2, Chicago, IL
Association of Oncology Social Work (AOSW) June 11-13, Atlanta, GA
National Infusion Center Association (NICA) June 20-21, Miami Beach, FL
ATMRD – Advanced Therapeutics in Movements & Related Disorders June 27-30, Washington, D.C.
Healthcare Advocate Summit (HAS) September 3-6, Las Vegas, NV
American Nurses Association (ANCC) October 8-10, Atlanta, GA
Mental Health America (MHA) October 15-17, Washington, D.C.
AASLD – The Liver Meeting November 7-11, Washington, D.C.
2025 Council of Medical Specialty Societies (CMSS) November 18-21, Washington, D.C.
American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting December 8-10, Las Vegas, NV
To view our past conferences, click here.
Getting the Word Out About HealthWell
Following is a carousel of featured content. Use the next and previous buttons to navigate.
North American Cystic Fibrosis Conference (NACFC), September 26 – 28, Boston, MA
Global Genes Rare Advocacy Summit, September 25 – 28, Kansas City, MO
Association of Physician Assistants in Oncology (APAO), August 29 – September 1, Nashville, TN
National Infusion Center Association (NICA), June 21 – 22, Las Vegas, NV
American Society of Clinical Oncology (ASCO), May 31 – June 4, Chicago, IL
HealthWell’s Recent Conference Panels
HealthWell is often honored with requests to moderate or participate in various health care and patient advocacy conferences. Following are some of our most recent panels and presentations.
Asembia’s 2025 Specialty Pharmacy Summit
IRA Series Part III – 2025 Early Results – “The New Normal” for the Medicare Part D Benefit Redesign and the Medicare Prescription Payment Plan (MPPP)
Date and Location: April 30, 2025, Las Vegas, Nevada
Objectives: Analyze specialty pharmacy implementation and management impact of the unintentional consequences of the Medicare Prescription Payment Plan on the 2025 Medicare Part D benefit redesign; Assess the impact to date and how the benefit redesign and MPPP are affecting multiple stakeholders (patients, health plans, providers, pharmacies, and pharma manufacturers) in the health care delivery system.
Moderator: Chuck Collins, President, Healthcare Stakeholder Solutions
Panelists: Fred Larbi, Chief Operations Officer, HealthWell Foundation; Eyad Farah, Chief Operating Officer, Orsini Specialty Pharmacy; Melissa Paige, President, National Association of Medication Access & Patient Advocacy
